Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Rectal Cancer

8 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Other

VICCGI0721

01/09/2007

Vanderbilt Hereditary Colorectal Cancer Registry

Supportive Care

VICCGI1416

08/19/2014

Programs to Support You During Chemotherapy (Pro-You)

Supportive Care

VICCREACH1341

09/05/2013

Using a Tailored Navigation Intervention to Prepare Patients and Their Support Person for the Journey at Time of Cancer Diagnosis and at Transition into Survivorship

Treatment

VICCGI13102

12/09/2014

A Phase II Study of Panitumumab in Combination with FOLFIRI after Progression on FOLFIRI plus Bevacizumab in KRAS and NRAS Wild Type Metastatic Colorectal Cancer

Treatment

VICCGI13101

06/24/2014

Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer

Treatment

VICCPHI1394

04/17/2014

A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients with Epithelial Cancer

Treatment

ECOGGIS0820

09/03/2013

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers